People were ineligible to participate in the study for a number of reasons, including having type 1 diabetes, if their A1C was over 9%, or if they were taking weight loss medications. The average ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

If you're at risk for diabetes or have noticed your glucose readings creeping up, your doctor may check your A1C as part of your routine blood work. An A1C test measures your average blood sugar ...

Overall A1c reduction at 1 year was 0.3 points with semaglutide and 0.4 with ... and 67.9% of those who stayed on the medications. Progression to type 2 diabetes occurred in 6.5%, 4.4%, ...

Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference. Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside ...

MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and Delivered Significant ...

The 100 mg daily dose of vildagliptin provided additional efficacy, achieving a placebo-adjusted A1C reduction of 1.2% at week 12, with no appreciable changes in A1C thereafter.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...